Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy

Conclusions: These results suggest that anti-VEGF treatment promotes glioma cell invasion via activation of Pyk2 . Inhibition of Pyk2 phosphorylation might be a potential target to ameliorate the therapeutic efficiency of anti-VEGF treatment.
Source: Journal of Translational Medicine - Category: Research Authors: Source Type: research